NRx Pharmaceuticals, Inc. (NRXP) - Balance Sheet Statement

Home
NRXP
Financials

1.265 (USD) • At close October 17, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	4.595	20.054	27.605	1.859	0	0.011	0.449
Short Term Investments Numbers are in millions	0	0	0	5.968	32.005	70.766	69.029
Cash and Short Term Investments Numbers are in millions	4.595	20.054	27.605	1.859	0	0.011	0.449
Net Receivables Numbers are in millions	0.006	0.007	0	0.831	0	0	0
Inventory Numbers are in millions	-0.006	-0.007	0	0.214	0	0	0
Other Current Assets Numbers are in millions	2.289	5.741	5.109	0.026	0.069	0.019	0.087
Total Current Assets Numbers are in millions	6.884	25.795	32.714	2.93	0.069	0.03	0.536
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	0	0	0	0	0	0	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0	32.005	70.766	69.029
Tax Assets Numbers are in millions	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.431	0.021	0.015	0.011	0	0	0
Total Non-Current Assets Numbers are in millions	0.431	0.021	0.015	0.011	32.005	70.766	69.029
Total Assets Numbers are in millions	7.315	25.816	32.729	2.941	32.075	70.796	69.566
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	4.632	2.076	3.687	3.153	0.622	0.551	0.086
Short Term Debt Numbers are in millions	9.161	8.703	0.518	0.249	0	0	0
Tax Payables Numbers are in millions	0	0	0	0.052	0.069	0.016	0
Deferred Revenue Numbers are in millions	0	0	2.844	0	0	0	0
Other Current Liabilities Numbers are in millions	5.255	5.806	4.874	42.762	0	0.016	0.008
Total Current Liabilities Numbers are in millions	19.048	16.585	11.923	46.164	0.622	0.567	0.093
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0	1.822	0	0.548	1.952	0.69	0
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0	0	0	0	0	0	0
Total Non-Current Liabilities Numbers are in millions	0	1.822	0	0.548	1.952	0.69	0
Total Liabilities Numbers are in millions	19.048	18.407	11.923	46.712	2.574	1.257	0.093
Equity:
Preferred Stock Numbers are in millions	0.003	0	0	0	0	0	0
Common Stock Numbers are in millions	0.084	0.067	0.059	0.043	24.503	64.541	64.475
Retained Earnings Numbers are in millions	-253.147	-223.059	-183.243	-90.18	0.369	-0.039	-0.105
Accumulated Other Comprehensive Income/Loss Numbers are in millions	-0.003	0	0	0	-24.503	0	0
Other Total Stockholders Equity Numbers are in millions	241.33	230.401	203.99	46.366	29.131	5.036	5.102
Total Shareholders Equity Numbers are in millions	-11.733	7.409	20.806	-43.771	29.5	69.539	69.473
Total Equity Numbers are in millions	-11.733	7.409	20.806	-43.771	29.5	69.539	69.473
Total Liabilities & Shareholders Equity Numbers are in millions	7.315	25.816	32.729	2.941	32.075	70.796	69.566

NRx Pharmaceuticals, Inc.

NASDAQ:NRXP Add to watchlist

NASDAQ:NRXP